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Abstract.  A  novel heparan sulfate proteoglycan 
(HSPG) present in the extracellular matrix of rat liver 
has been partially characterized.  Proteoglycans were 
purified from a high salt extract of total microsomes 
from rat liver and found to consist predominantly 
(~90%)  of HSPG. A  polyclonal antiserum raised 
against this fraction specifically recognized HSPG by 
immunoprecipitation  and immunoblotting.  The intact, 
fully glycosylated HSPG migrated as a broad smear 
(150-300 kD) by SDS-PAGE, but after deglycosylation 
with trifluoromethanesulfonic acid only a  single ~40- 
kD band was seen. By immunocytochemistry this 
HSPG was localized in the perisinusoidal  space of 
Disse associated with irregular clumps of basement 
membrane-like extracellular matrix  material,  some of 
which was closely associated with the hepatocyte sinu- 
soidal cell surface. It was also localized in biosyn- 
thetic compartments  (rough ER and Golgi cisternae) of 
hepatocytes, suggesting that this HSPG is synthesized 
and deposited in the space of Disse by the hepatocyte. 
The anti-liver HSPG IgG also stained basement mem- 
branes of hepatic blood vessels and bile ducts as well 
as those of kidney and several other organs (heart, 
pancreas,  and intestine).  An antibody that recognizes 
the basement membrane HSPG found in the rat glo- 
merular basement membrane did not precipitate the 
150-300-kD rat liver HSPG. We conclude that the 
liver sinusoidal space of Disse contains a  novel popu- 
lation of HSPG that differs in its overall size,  its dis- 
tribution and in the size of its core protein from other 
HSPG (i.e.,  membrane-intercalated  HSPG) previously 
described in rat liver.  It also differs in its core protein 
size from HSPG purified from other extracellular ma- 
trix sources. This population of HSPG appears to be a 
member of the basement membrane HSPG family. 
H 
EPARAN sulfate  proteoglycans  (HSPG) l are impor- 
tant extracellular  matrix components that appear to 
have multiple functions among which are regulation 
of cell adhesion  (24, 35, 36), cell migration  and differentia- 
tion  (8,  23),  and basement membrane permeability  (18). 
Considerable structural  diversity  exists among  HSPG with 
two major  families  having  been described:  one  found  in 
basement membrane (9,  12, 42) and another that is associ- 
ated with the plasma membrane of many cells (6, 31, 32, 34). 
Two populations  of HSPG have been extracted  from rat 
liver: a detergent-soluble,  membrane-intercalated  HSPG (22, 
32) and a heparin-releasable  HSPG which binds to the cell 
surface via its glycosaminoglycan  (GAG) side chains  (21). 
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Previously a polyclonal antibody was raised against proteo- 
glycans purified from a detergent extract of rat liver micro- 
somes.  It proved to recognize  the presumptive membrane- 
intercalated  population  of HSPG, which were found to be 
associated with the sinusoidai domain of the hepatocyte plas- 
malemma and with biosynthetic and endocytic compartments 
of the hepatocyte (41). The nature of the heparin-releasable 
population  of HSPG is not yet established, but it has been 
suggested that these HSPG may represent a proteolyticaily 
cleaved form of the membrane-intercaiated  HSPG (21). 
The purpose of this study was to characterize  the heparin- 
releasable,  salt-extractable  population  of HSPG from  rat 
liver (22, 32). Toward this end, we raised an antibody against 
proteoglycans obtained by extraction of rat liver microsomes 
with high salt. Using the antibody, we have partially  charac- 
terized a novel population  of HSPG which was found to be 
associated with the liver perisinusoidal extracellular  matrix 
and basement membranes, rather than with the hepatocyte 
cell membrane.  This HSPG appears to represent a member 
of the family of basement membrane HSPG. 
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Na235S04 (carrier free) was obtained from ICN Radiochemicals  (Radio- 
isotope Division, Irvine, CA). Chondroitinase ABC was from Miles Scien- 
tific  Division (Naperville,  IL);  Superose  6,  Q  Sepharose,  and  Protein 
A-Sepharose were from Pharmacia Fine Chemicals (Piscataway, NJ), and 
Freund's complete and incomplete adjuvants were from Gibco Laboratories 
(Grand Island, NY).  Ultrapure urea was obtained from United States Bio- 
chemicals (Cleveland,  OH), and ultrapure guanidine hydrochloride  (gdn- 
HC1) was obtained from Bethesda Research  Laboratories (Gaithersburg, 
MD). Aprotinin was purchased from Boehringer-Mannheim  Biochemicals 
(Indianapolis, IN); autofluor and Ecoscint from National Diagnostics (Man- 
ville, IL); BCA protein assay reagents from Pierce Chemical Co. (Rockford, 
IL); and Immobilon polyvinylidene difluoride  (PVDF) transfer membrane 
from Millipore Corp.  (Bedford,  MA).  Mouse Engelbreth-Holm-Swarm 
(EHS) tumor laminin  was purchased from Collaborative  Research Inc. (Bed- 
ford, MA); human  plasma fibronectin  from Bethesda  Research Laboratories; 
and NBT/BCIP (alkaline phosphatase substrate) from Kirkegaard and Perry 
Laboratories, Inc. (Gaithersburg,  MD). All other chemicals were supplied 
by Sigma Chemical Co.  (St.  Louis,  MO). 
Antibodies 
Anti-basement  membrane HSPG (anti-BM HSPG) which was raised against 
proteoglycans  purified from rat glomeruli was  characterized elsewhere 
(Pietromonaco,  S. E, and M. G. Farquhar. J. Cell Biol.  107:909; 40, 42, 
43). It specifically precipitates  only HSPG from glomernlar proteoglycans 
(42) and from cultured glomerular epithelial cells (43) and stains all base- 
ment membranes by immunofluorescence.  TRITC-conjugated  goat anti- 
rabbit F(ab')2 was purchased from Tago, Inc.  (Burliagame,  CA),  and Fab 
fragments of sheep anti-rabbit IgG conjugated to HRP were obtained from 
Dr. J. Kim (Tago, Inc.).  Goat anti-rabbit IgG conjugated to 5 tun colloidal 
gold was purchased from Janssen Pharmacenticals, Inc. (Piscataway, NJ), 
and alkaline phosphatase-conjugate..d goat anti-rabbit IgG from Fisher Sci- 
entific (Springfield,  NJ). 
Biosynthetic Labeling 
For analytical characterization of liver HSPG, rats (125-150 g) were given 
two injections of 1 mCi [asS]sulfate (at t  -- 0 and 8 h), and the animals 
were killed 4 h after the last injection. 
Preparation and Extraction of  Rat Liver 
Total Microsomes 
Rats were perfused via the descending aorta with PBS, and the livers were 
quickly removed and placed on ice after which a total microsomal fraction 
(TM) was prepared from the livers (11). All buffers contained protease  in- 
hibitors (1 mM PMSE 5 mM benzamidine, 100 mM e-aminocaproic  acid, 
and 5 tLg/ml aprotinin).  The method for extraction of liver TM was based 
upon that used previously to differentially solubilize HSPG associated with 
the hepatocyte cell surface (21, 22, 32). Briefly, the TM pellet was gently 
homogenized  and extracted  with 2 M NaCI in Tris-buffered sucrose (250 
mM sucrose,  100 mM Tris, pH 7.4) for 30 min at 4°C. The extract was cen- 
trifuged at 100,000 g for 90 min, and the supernatant was diluted to 0.2 M 
NaC1 with urea buffer (8 M urea, 0.05 M sodium acetate, pH 6.0, and 0.5% 
Triton X-100) for subsequent  ion exchange chromatography. 
Ion Exchange Chromatography 
Proteoglycans were isolated by ion exchange chromatography  using  Q Sepha- 
rose, eluting with a 0.2-1.0 M NaCI linear gradient at a flow rate of 15 ml/h 
(43).  1 ml fractions were collected and aiiquots were analyzed for radioac- 
tivity. Fractions containing [3SS]sulfate-labeled proteoglycans were pooled, 
diluted to <0.2 M NaCI with urea buffer and subjected to a second, concen- 
trating ion exchange step over a 200-#1 Q Sepharose column. For samples 
to be analyzed directly by gel filtration chromatography,  the column was 
eluted with 4  M  gdnHC1, 0.05 M  sodium  acetate, pH 6.0, 0.5 % Triton 
X-100. For samples to be subjected to enzymatic or chemical treatments be- 
fore gel filtration chromatography or imrnunoprecipitation,  the column was 
eluted with 100 mM Tris-HCl,  pH 8.0, 1 M NaC1. 
Gel l~ltration Chromatography 
Analytical  gel filtration chromatography was performed using a Superose 
6 FPLC column  equilibrated in 4 M gdnHCi, 0.05 M sodium acetate, pH 
6.0, 0.5%  Triton X-100 (47).  Pmteoglycan samples  (0.2  ml) containing 
2,000-20,000 cpm were  injected onto the column, and 0.4-ml  fractions 
were collected at 24 ml/h. Aliquots were diluted with 70% ethanol and ana- 
lyzed for radioactivity.  The void volume (Vo) and total volume (Vt) of the 
column were determined with blue dextran and [3H]serine,  respectively. 
Enzymatic and Chemical Treatments 
Chondroitinase ABC digestion  (0.1 U/0.1-ml sample)  was carried out at 
37°C for 1 h in the presence of 50 mM sodium acetate and protease inhibi- 
tors (2 mM N-ethylmaleimide,  1 mM PMSE  10 #g/ml pepstatin).  If the 
samples were to be separated by gel filtration (to determine the relative 
amounts of heparan sulfate to chondroitin/dermatan sulfate proteoglycan), 
an equal volume of 8 M gdnHC1, 1% Triton X-100 was added to the digested 
material, and the sample was loaded directly onto the Superose 6 column. 
For immunoprecipitation, an equal amount of  2 x  RIPA buffer (50 mM Tris- 
HC1, pH 7.3, 0.15 M NaC1, 1% Triton X-100, 0.1% SDS, and 10 mM EDTA) 
was added to the samples. 
Nitrous acid deamination was conducted  (20°C for 1 h) according to 
Cifonelli and King (7). Briefly, 0.1 ml of ion exchange purified proteoglycan 
in 100 mM Tris-HC1, pH 8.0, 1 M NaCI, was lyophilized and reconstituted 
with 0.1 ml 0.2 M NaNO2 in 3.5 M acetic acid.  The reaction was termi- 
nated by neutralization  with 1 M Tris, pH 10, and the digested material was 
diluted with an equal volume of either 8 M gdnHC1, 0.05 M sodium acetate, 
pH 6.0, 1% Triton X-100 for gel filtration, or with 2 x RIPA buffer for immu- 
noprecipitation. 
Alkaline /~-elimination of O-linked  GAG chains was  conducted  with 
0.05 N NaOH and 1 M NaBI-I4 according  to Carlson (5). After digestion 
for 24 h at 45°C,  the sample was adjusted to 4 M gdnHC1, 0.05 M sodium 
acetate,  pH 6.0, 0.5%  Triton X-100, and analyzed by gel filtration. 
Chemical  deglycosylation  of the proteoglycan  was  carried  out  with 
trifluoromethanesulfonic  acid (TFMS) according to Edge and Spiro (10), 
with minor modifications.  In brief, "-,10-25 ~g ion exchange purified pro- 
teoglycan from unlabeled rat liver was dialyzed against 10 mM ammonium 
bicarbonate, pH 8.6, and lyophilized in Reacti-vials (Pierce Chemical Co.). 
Anisole (20 #1) and TFMS (30 #1) were added to the dried samples on ice, 
the Reacti-vials sealed and purged with nitrogen, and the reaction carried 
out at 0°C with constant stirring for 4-6 h. The sample was transferred to 
-70°C (10-15 min), after which ice-cold  pyridine:H20 (1:1) (150 ~tl) was 
added dropwise,  while the sample was kept cool in an ice bath. It was then 
dialyzed against  10 mM Tris, pH 6.8, for 12-24 h with many changes,  ex- 
tracted with anhydrous ether (three times), lyophilized, and finally resolubi- 
lized in SDS sample buffer (0.15 M Tris, pH 6.8, 10% SDS, 25% glycerol, 
5 % j3-mercaptoethanol,  and bromophenol blue) before electrophoresis. 
Preparation of  Antigen 
Total microsomes were prepared from unlabeled rat livers and extracted as 
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Figure 1. Ion exchange chromatography of [asS]sulfate-labeled pro- 
teoglycans purified from rat liver microsomes.  Total microsomes 
were prepared from biosynthetically labeled rat liver as described 
in Materials and Methods, extracted with 2 M  NaCI, applied to a 
Q  Sepharose column, and eluted with a 0.2-1.0 M  NaCI gradient 
(40 ml each).  1-ml fractions were collected, and aliquots (20 ~1) 
were counted for radioactivity. Liver proteoglycans elute in a single 
peak between 0.5 and 0.9 M  NaC1 (bracket). 
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Figure 2.  Gel filtration chromatography of proteoglycans from rat 
liver microsomes. Radiolabeled  proteoglycans were purified by two 
passes over Q  Sepharose, and gel filtration chromatography per- 
formed under FPLC conditions (<170 psi, 24 ml/h) using a Su- 
perose 6 column. Proteoglycans (200 #1, '~20,000 cpm) were ap- 
plied  to  the  column  in  gdnHCl  buffer,  and  0.4  ml  fractions 
collected. (A) Approximately 88 % of the proteoglycan elutes early 
from the column in two poorly resolved peaks (K, 0.26 and 0.39). 
The remainder of the counts are found in a small peak (K~ 0.81). 
(B) Nitrous acid deamination of the proteoglycan reduces most of 
the material to small fragments which elute in the Vt. (C) Alkaline 
B-elimination results in a shift to a broad peak (K~ 0.65),  indicat- 
ing extensive heterogeneity of GAG chains. 
Antibody Preparation 
A rabbit was immunized  via the popliteal lymph nodes following  precisely 
the procedure of Louvard et al. (26). The initial injection consisted of 30 
/~g protein emulsified  in CFA. Subsequent  boosts (20/zg) were given at days 
22, 32, and 33, and the animal was bled 1 wk later. IgG was purified from 
serum by ammonium sulfate precipitation. 
Immunocytochemistry 
Rat tissues were fixed by retrograde perfusion with periodate-lysine-para- 
described above. Tracer [35S]sulfate-labeled  proteoglycan  was added to the 
extract which was separated by ion exchange chromatography. Fractions 
from the Q Sepharose column containing the proteoglycan  were pooled (see 
Fig. 1) and precipitated with ice-cold 95 % ethanol (5-6 vol). Protein con- 
tent of the precipitate was determined by the Pierce BCA assay. The yield 
was "~,10 #g proteoglyean/g liver tissue. 
Figure  3.  Immunoprecipitation of [35S]sulfate-labeled  HSPG  by 
anti-liver HSPG IgG. Proteoglycans were purified by ion exchange 
chromatography from a 2 M  NaC1 extract of biosynthetically la- 
beled rat liver microsomes and separated by SDS-PAGE (lane A). 
Immunoprecipitation  was carried out as described in Materials and 
Methods  using  anti-liver HSPG  IgG  (lanes E,  G,  I),  anti-BM 
HSPG IgG (lane C), or preimmune IgG (lanes B, D, E  H). Pro- 
teoglycan ('~50,000 cpm) was either precipitated directly (lanes 
B-E) or subjected to chondroitinase ABC (lanes F and G) or ni- 
trous acid (lanes H and I) treatment prior to precipitation. Ion ex- 
change purified proteoglycans migrate on SDS-PAGE as a broad, 
diffuse smear, 150-300 kD, or barely enter the resolving gel (lane 
A). Anti-liver HSPG IgG precipitates a  heterogeneous group of 
proteoglycans that appear as a  broad smear  150-300  kD and  a 
weaker, heterogeneous band at '~82 kD (lane E). Precipitation of 
the  upper  broad  band  is  not  affected by  treatment  with  chon- 
droitinase ABC (lane G), but is eliminated by nitrous acid deamina- 
tion (lane I). Anti-BM HSPG IgG precipitates HSPG, which barely 
enters the resolving gel (lane C). Preimmune IgG does not precipi- 
tate pS]sulfate-labeled macromolecules (lanes B, D, F, H). 
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sodium periodate in phosphate buffer [30]), followed  by immersion (6 h) 
in the same fixative. For immunofluorescence, semitbin frozen sections 
(0.5 gm) were prepared on a Reichert Ultracut OMU-4 ultramicrotome 
equipped with a cryoattachmetu  as described elsewhere (39). Sections  were 
incubated sequentially with preimmune or immune serum (1:200 in PBS, 
0.1% ovalbumin, pH 7.4 for 2 h), followed by TRITC-anti-rabbit F(ab~2 
conjugate (1:200 for 2 h). The sections were examined by epifluorescence 
and photographed in a Zeiss Photomicroscope III (Kodak Tri-X Pan ASA 
400). 
For immunoperoxidase, cryostat sections (20-30 #m) cut from PLP- 
fixed, fasted rat liver were incubated with immune IgG (1:100) overnight, 
followed  by incubation with Fab fragments  of sheep anti-rabbit IgG conju- 
gated to HRP (1:50) for 2 h. They were then fixed in 3% glutaraldehyde 
in 0.1 M sodium cacodylate buffer, reacted with DAB, and processed for 
electron microscopy as detailed elsewhere (4). 
Immunogold labeling on ultrathin frozen sections was performed as de- 
scribed by Tokuyasu  (45). Ultrathin cryosections  were cut from rat liver tis- 
sue at =110"C on a Reichert OMU-4 equipped with a cryoattachment. Sec- 
tions Were incubated for  1 h  with immune IgG (diluted 1:30 in PBS 
containing 10% FBS), followed  by goat anti-rabbit IgG conjugated  to 5 nm 
colloidal gold (diluted 1:50). They were then postfixed in 2% glutaralde- 
hyde in PBS (10 min), stained with 2% OsO4 (10 min), followed by 2% 
acidic uranyl acetate (20 min), and finally absorption stained (5 rnin) with 
0.002 % lead citrate in 3 % polyvinyl alcohol (46). 
Immunoprecipitation 
Ion exchange-purified  proteoglycans (10,000-50,000 cpm) obtained from 
[35S]sulfate-labeled  rat liver TM were incubated with 20 #1 preimmune se- 
rum in 1 ml RIPA buffer for 30 min at 20°C, after which 5 mg Protein 
A-Sepharose  beads were added (1 h). After centrifugation,  the cleared super- 
natants were incubated (1  h) with 20 #1 of immune IgG, 5 mg Protein 
A-Sepharose beads were added, and the antigen-antibody mixture incu- 
bated overnight at 4°C. After extensive washing (four changes of RIPA 
buffer over 4 h, one change PBS, two changes distilled water), the immuno- 
precipitates were solubilized  in SDS-PAGE  sample buffer (0.15 M Tris, pH 
6.8, 10% SDS, 25% glycerol, 5%/~-mercaptoethanol, bromophenol blue) 
and separated  on 5-10 % gradient Laemmli po!yacrylamide  gels. Fluorogra- 
phy was conducted  using Autofluor,  and the gels exposed to Kodak  X-Omat 
AR x-ray film in the presence of an intensifier screen. 
lmmunoblotting 
Ion exchange-purified  proteoglycans  were obtained from 2 M NaCI extracts 
of unlabeled rat liver TM. Intact and TFMS deglycosylated  proteoglycans 
(10-25 ~g), mouse EHS laminin (1 t,g), and human plasma fibronectin (1 
#g) were separated  by SDS-PAGE  under denaturing conditions, and the sep- 
arated proteins were electrophoretically transferred to Immobilon mem- 
branes (150 mA for 15-18 h at 4°C). Unbound sites on the membrane were 
blocked by incubation in 5% nonfat dry milk, 1% Tween 20 in PBS (1 h 
at 20°C). Immunoreactive bands were detected by sequential incubation 
with immune IgG (1:1,000), alkaline phosphatase-conjngated anti-rabbit 
IgG, and NBT/BCIP substrate. 
Results 
Chromatographic Analysis of  Liver HSPG Extracted 
by 2 M NaCl 
When a  TM fraction prepared from rat liver was extracted 
with  2  M  NaC1,  ,o25 %  of the  total 35S  radioactivity was 
solubilized.  80-95 %  of these  counts  bound  to,  and  were 
eluted from the ion exchange column in a single peak between 
0.5 and 0.9 M  NaC1 (Fig.  1). Analysis of the proteoglycans 
pooled from this peak by gel filtration chromatography indi- 
cated that most of the counts (~88%)  eluted as two poorly 
resolved peaks, Kav 0.26 and 0.39,  while ~12%  eluted in a 
minor peak, Kay 0.81  (Fig. 2 A). Pretreatment of the sample 
with chondroitinase ABC removed only  10-15 %  of the 35S 
radioactivity from the  major peak  (data not  shown).  The 
counts  were  depleted equally from  the  Kay 0.26  and  0.39 
peaks but the minor peak at Kay 0.81  was unchanged.  Ni- 
trous acid domination before chromatography reduced the 
majority of the high molecular weight material to small frag- 
ments that eluted in the E  (Fig. 2 B). The lack of suscepti- 
bility of the fraction to chondroitinase ABC, together with 
its sensitivity to nitrous acid deamination, indicate that most 
of the sample consists of HSPG. Alkaline ~-elimination re- 
leased GAG chains with a complex elution profile, the major 
peak being K~v 0.65  (Fig.  2  C).  The  complex profile sug- 
gests a  bimodal pattern with the trailing edge representing 
the  original Kav 0.81  peak,  which  most  likely consists  of 
intracellular degradation products. The large peak at the Vt 
probably represents free  sulfate released by alkaline treat- 
ment. The complexity of the pattern is most likely due to ex- 
tensive heterogeneity of GAG chains which is known to oc- 
cur in other proteoglycans. 
Characterization of the Anti-Liver HSPG IgG 
by Immunoprecipitation and Immunoblotting 
When polyclonal IgG generated against liver proteoglycans 
purified from a high salt extract of TM was used to precipi- 
tate biosynthetically labeled proteoglycan, a broad, smeared 
band (150-300 kD) was precipitated along with high molec- 
ular weight material at the top of the resolving gel (Fig. 3, 
lane E).  The predominant smeared band centered near the 
200-kD  molecular  weight  marker  had  the  typical diffuse 
profile characteristic of proteoglycans, which is due to the 
attached GAG chains. Sometimes a minor band at 82 kD (not 
seen in the original starting material) was also seen, but this 
Figure 4.  Immunoblotting of 
liver proteoglycans  before and 
after TFMS deglycosylation. 
Proteoglycans purified by ion 
exchange chromatography  from 
a  2  M  NaC1 extract of unla- 
beled  rat  liver  microsomes 
were separated by SDS-PAGE 
under  denaturing  conditions 
and transferred to Immobilon 
membrane.  Anti-liver HSPG 
IgG reacts with intact proteo- 
glycans of heterogeneous size 
visualized as a  broad smear, 
150-300  kD (lane A).  After 
TFMS treatment, the antibody 
recognizes a 40-kD core pro- 
tein  (lane B).  The  unbound 
fraction of the  Q  Sepharose 
column contains many proteins 
demonstrated  by  Coomassie 
blue staining (lane D);  none 
reacts with the polyclonal IgG 
(lane C). 
The Journal  of  Cell  Biology, Volume  113, 1991  1234 Figure 5. Indirect immunofluorescence  staining of semithin (0.5/~m)  cryosections prepared from various PLP-fixed  rat tissues with anti-liver 
HSPG. (A and B) Liver: strong staining is seen of  the perisinusoidal regions (arrows)  and of  basement membranes of the blood vessels (V) 
and bile capillaries (Bc) in the portal triad. Staining of  the perisinusoidai extracellular matrix (arrows) is shown at higher magnification in B. 
(C) Kidney: the glomerular basement membranes (G), Bowman's capsule, and basement membranes of tubules (T) and peritubular capil- 
laries are stained. (D) Heart: cross-section of cardiac muscle from the left ventricle. The antibody reacts strongly with the basement mem- 
branes surrounding the myocytes and capillaries. (E) Pancreas: the capillary basement membranes and those surrounding the pancreatic 
lobules at the basal surface of the acinar cell are stained. (F) Small intestine: the basement membranes underlying the epithelial cells 
and surrounding the capillaries and lymphatics in the lamina propria are stained. Bars: (A, C, E, and F) 20 t~m; (B and D) 10 #m. 
was an inconsistent finding; it may represent a breakdown 
product generated during the immunoprecipitation proce- 
dure. Pretreatment of the sample with chondroitinase ABC 
had no effect on the precipitation of the broad 150-300-kD 
band (Fig. 3, lane G), whereas the latter was not seen after 
treatment with nitrous acid (Fig. 3, lane I), which degrades 
HSPG. No radiolabeled material was precipitated by preim- 
mune IgG (Fig. 3, lanes B, D, F, and H). When an antibody 
(anti-BM  HSPG) raised against  glomerular proteoglycans 
that recognizes kidney and other basement membranes (42) 
was  used for immunoprecipitation, only material  of high 
molecular mass which barely entered the resolving gel was 
precipitated (Fig. 3, lane C). This indicates that the anti-liver 
HSPG, but not the anti-BM HSPG recognized and precipi- 
tated a population of HSPG which migrates at "¢150-300 kD 
on SDS gels. 
The anti-liver HSPG also detected a similar broad 150- 
300 kD band by immunoblotting of purified liver proteogly- 
cans (Fig. 4,  lane A), and,  similarly, prior treatment with 
chondroitinase ABC  did not alter the reactivity (data not 
shown). When purified liver proteoglycans were chemically 
deglycosylated with TFMS before SDS-PAGE (to remove 
GAG chains and N- and O-linked oligosaccharides), the anti- 
body recognized a  ,~40-kD core protein (Fig. 4, lane B). 
The flowthrough (unbound fraction) from the Q Sepharose 
column was also tested for immunoreactivity with anti-liver 
HSPG. As anticipated, many Coomassie blue-stained bands 
were present in the flow-through (Fig. 4, lane D), but none 
Soroka and Farquhar Novel ECM Heparan Sulfate Proteoglycans from Rat Liver  1235 Figure 6. Immunoperoxidase localization  of liver HSPG. Cryostat sections were incubated with anti-liver HSPG IgG followed by Fab frag- 
ments of sheep anti-rabbit IgG and processed as described in Materials and Methods. (A) Peroxidase reaction product is detected around 
the sinusoids (S) in the space of Disse (D), where it is associated with clumps of extracellular matrix material located between the en- 
dothelium (En) and the sinusoidal surface of the hepatocyte (He). (B) Enlargement of the space of Disse showing reaction product (arrow- 
heads) located between processes of the sinusoidal endothelium (En) and the bepatocyte (He) microvilli. Reaction product is also seen 
in association with the hepatocyte and endothelial plasma membranes. (C) In a less strongly reacted specimen, clumps of reactive extracel- 
lular matrix material (arrowheads) are seen to be located in close proximity to the adjacent endothelial and hepatocyte cell membranes 
in the space of Disse (D). K, Kupffer cell. Bars: (A and C)  1 pm; (B) 0.5 ~m. 
The Journal of Cell Biology,  Volume 113, 1991  1236 Figure Z Immunopcroxidase localization of liver HSPG in the bile duct epithelium (A) and in hepatocytes (B and C)). Preparation similar 
to that in Fig. 6. (A) The basement membrane (BM) surrounding a bile duct in the portal triad is strongly reactive for this HSPG. The 
core protein of this HSPG is also detected within the rough ER (er) and Golgi (G) cisternae of the bile duct epithelium (EP). (B and C) 
Small fields demonstrating reaction product in the stacked Golgi cisternae (G) and rough ER (er) of hepatocytes. L, lumen of the bile 
duct; Cis, cis side of Golgi; Trans, trans side of the Golgi; mv, multivesicular endosome. Bars: (A and B) 1 ~tm; (C) 0.5 /~m. 
of them stained with the anti-liver HSPG IgG (Fig. 4, lane 
C), thus confirming the specificity of the antibody for the 
tightly bound proteoglycan fraction. No reactivity with lam- 
inin or flbronectin was  detected by immunoblotting or by 
ELISA (data not shown). 
These data indicate that the antibody raised against the 
proteoglycans extracted by high salt from liver microsomes 
specifically recognizes by both immunoprecipitation and im- 
munoblotting a population of HSPG (150-300 kD) with a 40- 
kD protein core. This population of HSPG is not recognized 
by the  anti-BM  HSPG  raised  against  glomerular proteo- 
glycans. 
lmmunocytochemical Localization of Liver HSPG 
When the anti-liver IgG was used for indirect immunofluo- 
rescence on semithin (0.5 #m) sections from rat liver, there 
was strong staining of the perisinusoidal region, as well as 
of basement membranes  of the vessels of the portal triad 
(Figs. 5, A and B). The sinusoidal staining appeared as an 
interrupted, punctuate fluorescence pattern surrounding the 
sinusoids (Fig. 5 B). Staining of basement membranes was 
also seen in all organs examined, including kidney (Fig. 5 
C), heart (Fig. 5 D), pancreas (Fig. 5 E), and intestine (Fig. 
5 F). Interestingly, when the anti-BM HSPG antibody pre- 
pared from glomerular proteoglycans was used to stain rat 
liver, only the basement membranes of the bile ducts and 
large blood vessels of the portal triad were stained. No reac- 
tivity was seen with the extracellular matrix material in the 
space of Disse. 
When the HSPG recognized by the anti-liver HSPG IgG 
was localized at the electron microscopic level by immuno- 
peroxidase, the perisinusoidal staining was seen to be due to 
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a 5-nm gold-anti-rabbit IgG conjugate. (A) Most of  the gold particles (arrows)  are associated with clumps of  barely discernable extracellular 
matrix material located in the space of Disse (D) between the endothelium (En) and the sinusoidal plasma membrane domain of the hepato- 
cyte (He). (B) Another field of a similar preparation showing the proximity of the HSPG to the sinusoidal domain of the hepatocyte plasma 
membrane (arrows) facing the space of Disse (D). Bar, 0.1 /~m. 
the presence of this HSPG in the space of Disse. Aggregates 
of reaction product were located between the abluminal sur- 
face of the endothelium and the sinusoidal plasmalemma of 
the hepatocyte (Fig. 6, A-C). In lightly reacted specimens 
(Fig. 6 C), reaction product was seen to be associated with 
ill-defined clumps  of extracellular matrix material  in  the 
space of Disse. Sometimes small amounts of reaction prod- 
uct were closely associated with the epithelial and endothe- 
lial plasma membranes adjacent to the reactive extracellular 
matrix. However, little or no reaction product was seen on 
the bile canalicular membrane or lateral surfaces of the he- 
patocyte below  the junctional  complexes.  The  basement 
membranes of the blood vessels and bile ducts of the portal 
triad (Fig. 7 A) were also heavily reactive. Moreover, reac- 
tion product was found within the ER and Golgi cisternae of 
both the hepatocytes (Figs. 7, B and C) and the bile duct epi- 
thelium (Fig. 7 A). The presence of reaction product within 
biosynthetic compartments  indicates  that  both  these  cell 
types synthesize HSPG recognized by the antibodies. 
Results of immunogold localization of this HSPG on ultra- 
thin cryosections confirmed results obtained by immunoper- 
oxidase.  Gold particles were mainly found in  association 
with extracellular matrix material in the space of Disse (Fig. 
8 A).  They were also found in clusters along the hepato- 
cyte plasmalemma (Fig.  8 B), suggesting close association 
of the extracellular matrix material with the surface of the 
hepatocyte. 
Thus, the anti-liver HSPG IgG we generated recognizes a 
population of HSPG found in the perisinusoidal extracellular 
matrix and  basement  membranes  of the  rat liver.  It also 
reacts with HSPG present in basement membranes of many 
other rat tissues. 
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We have previously shown that two antigenically distinct 
populations of HSPG can be distinguished in liver, kidney 
and other cells: one type of HSPG is associated with cell 
membranes and the other with basement membranes. These 
two types of proteoglycans are found both in situ in intact 
liver (41) and kidney (14, 42) and in cultured liver and kidney 
cell lines (40, 43). In the present study we set out to charac- 
terize the heparin/salt-releasable type of HSPG described in 
rat liver which was suggested to represent a proteolytically 
cleaved form of the membrane-associated HSPG. An anti- 
body raised against proteoglycans purified from a high salt 
extract of rat liver microsomes proved to recognize exclu- 
sively HSPG by immunoprecipitation and immunoblotting 
and to stain irregular clumps of  basement membrane-like ex- 
tracellular matrix material deposited in the liver sinusoidal 
space of Disse and with basement membranes of the blood 
vessels and bile duct epithelium of the portal triads. Thus, 
the immunocytochemical results indicate that the HSPG rec- 
ognized are associated with the extracellular matrix rather 
than with cell membranes. Moreover, the anti-liver HSPG 
stained basement membranes of kidney and other tissues 
(heart, pancreas, intestine). The pattern was comparable to 
that obtained with antibodies raised against HSPG purified 
from other basement membrane sources, e.g., renal glomer- 
uli (42) and the EHS sarcoma (17, 20) and was quite different 
from that obtained with an antibody that recognizes mem- 
brane  intercalated HSPG  (40,  41).  The  anti-liver  HSPG 
showed no reactivity by immunoblotting or ELISA with lam- 
inin or fibronectin. Moreover, the antibody precipitates from 
a rat liver proteoglycan fraction a population of HSPG with 
a mobility of 150-300 kD (by SDS-PAGE) with an ,~40-kD 
core protein (after TFMS deglycosylation). The overall size 
of this population of HSPG and its core protein size differ 
from those of the membrane-intercalated HSPG previously 
found to be associated with plasma membranes of rat liver 
(41) which have an overall size of ~80 kD with an ~20-kD 
protein core (22).  Thus, the immunochemical data we ob- 
tained indicate that the antibody recognizes the core protein 
of a  population of extracellular matrix-associated HSPG 
found in rat liver that differs in its properties from the mem- 
brane-intercalated HSPG from rat liver. It also differs in its 
overall size and core protein size from HSPG purified from 
other extracellular matrix sources, especially kidney base- 
ment membranes. 
A  good deal of size diversity has been reported among 
HSPG from different extracellular matrix sources (28, 44). 
For example, the EHS sarcoma which makes a  basement 
membrane-like matrix contains two (high and low density) 
HSPG, 650 and 130 kD, with core proteins of 450 and 21-34 
kD, respectively (19, 25),  whereas HSPG from the bovine 
(10) and rat (33) glomerular basement membrane have been 
reported to be 200-400 kD, with a core protein of 130 kD 
(determined by TFMS treatmen0. Further evidence suggest- 
ing differences between the liver and glomerular basement 
membrane HSPG is that an antibody we raised previously 
against glomerular proteoglycans fails to precipitate the 150- 
300 kD HSPG from rat liver, and it fails to stain the clumps 
of basement membrane-like matrix in the space of Disse (al- 
though it does stain basement membranes of liver arterioles, 
vermles  and bile  ducts).  Similar  immunostaining results 
were obtained by Couchman (9) and Schleicher et al. (38) 
with antibodies raised against HSPG purified from PYS-2 
cell cultures and porcine glomeruli, respectively. Previously 
it has been shown that the BM-1 antibody raised against EHS 
sarcoma HSPG does stain the perisinusoidal matrix (15, 16). 
These results suggest that the anti-liver HSPG IgG we have 
generated recognizes a novel HSPG present in the liver peri- 
sinusoidal extracellular matrix that shares some epitopes in 
common with other basement membrane HSPG but has one 
or more antigenic determinants which are  recognized by 
some but not all antibodies raised against basement mem- 
brane HSPG. 
Cellular Sources of  Basement Membrane HSPG 
in Rat Liver 
The  hepatocyte most  likely represents  the  main  cellular 
source of the HSPG we have used as immunogen because the 
hepatocyte is by far the predominant liver cell type and a to- 
tal microsome fraction from rat liver would be expected to 
be composed of vesicles derived primarily from this cell 
type. Other cell types present (Kupffer cells, endothelial cells, 
bile duct epithelium, fat-storing cells) contribute <5%  of 
the total microsome fraction (2),  which was the starting 
material for the salt extraction. Microsomes contain vesi- 
cles derived from both intracellular compartments (rough 
and smooth ER, Golgi, vesicular carriers, endosomes) and 
from the plasma membrane. Therefore, the HSPG extracted 
from liver microsomes would be expected to be derived pri- 
marily from hepatocytes and would include not only those 
from ER and Golgi vesicles containing biosynthetic precur- 
sors in transit through hepatocytes, but also those from plas- 
malemmal vesicles presumably with amorphous clumps of 
extracellular matrix still  attached.  That the proteoglycans 
can be extracted from microsomes with 2 M NaC1 is compat- 
ible with the earlier assumption (21) that these HSPG are 
bound to the cell membrane or to other extracellular matrix 
components via electrostatic interactions. 
Previous studies conducted on primary cultures of isolated 
hepatocytes and lipocytes have reported that the primary 
source of sinusoidal extracellular matrix components (lami- 
nin,  collagen IV,  and  HSPG)  in the liver is the lipocyte 
(perisinusoidal stellate cell or fat-storing cell) (1, 15, 27, 37). 
However,  in this study we have demonstrated by immuno- 
electron microscopy the presence of  the core protein of  base- 
ment membrane HSPG in biosynthetic compartments (ER 
and Golgi cisternae) of both the hepatocyte and the bile duct 
epithelium.  This suggests that the hepatocyte most likely 
synthesizes and deposits HSPG in the perisinusoidal matrix, 
whereas the bile duct epithelium synthesizes and deposits 
HSPG in their basement membranes.  Furthermore, in an 
earlier study, we demonstrated the presence of membrane- 
associated HSPG in the intracellular compartments of hepa- 
tocytes  (41) using  an  antibody  that  recognizes  only the 
membrane-associated type of HSPG.  These data indicate 
that the hepatic parenchymal cell synthesizes both cell mem- 
brane and basement membrane-type HSPG which are the 
only HSPG from liver that have been characterized to date. 
Interestingly, Brandan and Hirschberg (3) have shown that 
there  is a  temporal  (precursor-product?)  relationship be- 
tween a hydrophobic, Golgi-associated form of HSPG and 
hydrophilic, plasma membrane-associated HSPG. Our re- 
suits demonstrate that the basement membrane and cell mem- 
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sizes and different distributions  once released from the cell. 
Whether or not the HSPG studied  by Brandan and Hirsch- 
berg corresponds to the 150-300-kD HSPG with the 40-kD 
protein core identified in this study remains to be determined. 
Diversity among Basement Membrane HSPG 
Our data  add to the growing evidence for the existence of 
heterogeneity in HSPG populations associated with different 
basement membrane sources. The size difference and the ex- 
istence of unique epitope(s) in the perisinusoidal population 
of liver HSPG suggests that there  may be differences in its 
amino acid sequence or in its conformation as compared to 
HSPG  derived  from other  sources.  That there  should be 
structural differences between HSPG derived from different 
types of basement membranes is logical, because there are 
vast differences in the organization and functions of base- 
ment membranes  in different locations.  This is especially 
notable when comparing the renal glomerular basement mem- 
brane with the loosely organized basement membrane-like 
matrix found in the space of Disse in the liver.  The former 
is a uniform and compact basement membrane layer which 
is organized into a continuous sheet (in three  dimensions) 
made up of a tight, well-defined latticework that functions as 
a refined macromolecular filter restricting passage of anionic 
molecules >70 A effective molecular radius (13). By contrast, 
in the liver, where the sinusoids form an open network with 
a discontinuous endothelium, there is no typical basement 
membrane layer. The surface of the hepatocyte is in direct 
contact with the blood plasma, and the endothelium is sep- 
arated  from the hepatocyte  plasmalemma by  the  space of 
Disse, which contains occasional collagen fibrils and irreg- 
ular clumps of extracellular matrix material  (29). The latter 
is known to contain collagen HI and basement membrane 
components,  such as collagen IV,  fibronectin, and laminin 
(16, 27, 29), as well as basement membrane-type HSPG (15, 
16). The function of this loosely organized matrix composed 
largely  of basement membrane proteins is unknown,  but, 
since it is discontinuous, it seems unlikely that it has a major 
filtration  function. 
HSPG are known to differ widely in their hydrodynamic 
properties due in large part to the number and size of their 
GAG chains. That genuine differences also exist in the size 
of their core proteins is also now generally accepted (28, 44). 
However, at present it is not clear how much of the size diver- 
sity is generated by differential  proteolytic processing of a 
common precursor,  by  differential  splicing of mRNA,  or 
whether they represent separate gene products.  The explana- 
tion will become apparent only when DNA sequence data is 
available on the core proteins of basement membrane HSPG 
derived from a variety  of sources. 
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